Dashboard
Manage Tickers

INO INOVIO PHARMACEUTICALS, INC.

Nasdaq inovio.com


$ 2.02 $ 0.00 (-0.25 %)    

Tuesday, 11-Nov-2025 19:26:29 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 622.49 $ 0.90 (0.15 %)
DIA $ 479.63 $ 5.34 (1.13 %)
SPY $ 683.37 $ 2.90 (0.43 %)
TLT $ 89.91 $ 0.01 (0.01 %)
GLD $ 380.58 $ -0.09 (-0.02 %)
$ 2
$ 2.00
$ 1.95 x 4,009
$ 2.14 x 88,411
$ 1.90 - $ 2.05
$ 1.30 - $ 5.40
3,408,677
na
107.14M
$ 1.68
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-10-2025 09-30-2025 10-Q
2 08-12-2025 06-30-2025 10-Q
3 05-13-2025 03-31-2025 10-Q
4 03-18-2025 12-31-2024 10-K
5 11-14-2024 09-30-2024 10-Q
6 08-08-2024 06-30-2024 10-Q
7 05-13-2024 03-31-2024 10-Q
8 03-06-2024 12-31-2023 10-K
9 11-09-2023 09-30-2023 10-Q
10 08-09-2023 06-30-2023 10-Q
11 05-10-2023 03-31-2023 10-Q
12 03-01-2023 12-31-2022 10-K
13 11-08-2022 09-30-2022 10-Q
14 08-09-2022 06-30-2022 10-Q
15 05-10-2022 03-31-2022 10-Q
16 03-01-2022 12-31-2021 10-K
17 11-09-2021 09-30-2021 10-Q
18 08-09-2021 06-30-2021 10-Q
19 05-10-2021 03-31-2021 10-Q
20 03-01-2021 12-31-2020 10-K
21 11-09-2020 09-30-2020 10-Q
22 08-10-2020 06-30-2020 10-Q
23 05-11-2020 03-31-2020 10-Q
24 03-12-2020 12-31-2019 10-K
25 11-12-2019 09-30-2019 10-Q
26 08-08-2019 06-30-2019 10-Q
27 05-09-2019 03-31-2019 10-Q
28 03-12-2019 12-31-2018 10-K
29 11-08-2018 09-30-2018 10-Q
30 08-07-2018 06-30-2018 10-Q
31 05-09-2018 03-31-2018 10-Q
32 03-14-2018 12-31-2017 10-K
33 11-08-2017 09-30-2017 10-Q
34 08-08-2017 06-30-2017 10-Q
35 05-10-2017 03-31-2017 10-Q
36 03-15-2017 12-31-2016 10-K
37 11-09-2016 09-30-2016 10-Q
38 08-08-2016 06-30-2016 10-Q
39 05-09-2016 03-31-2016 10-Q
40 03-14-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

inovio-pharma-prices-public-offering-of-13158m-common-shares-at-190shr
INOVIO Pharma Prices Public Offering Of 13...
11/11/2025 13:43:02

INOVIO Pharmaceuticals, Inc. (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to h...

inovio-prices-3158000-share-public-offering-at-190share
INOVIO Prices 3,158,000 Share Public Offer...
11/11/2025 13:41:49

update-inovio-pharmaceuticals-q3-adj-eps-044-misses-042-estimate
UPDATE: Inovio Pharmaceuticals Q3 Adj. EPS...
11/10/2025 23:44:05

Inovio Pharmaceuticals (NASDAQ:INO) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate ...

inovio-announces-proposed-public-offering-of-common-stock-no-size-or-amount-disclosed
INOVIO Announces Proposed Public Offering ...
11/10/2025 23:14:11

NOVIO Pharmaceuticals, Inc. (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to he...

earnings-scheduled-for-november-10-2025
Earnings Scheduled For November 10, 2025
11/10/2025 11:12:02

inovio-completes-rolling-bla-submission-for-ino-3107-in-treatment-of-rrp-in-adults
INOVIO Completes Rolling BLA Submission Fo...
11/03/2025 13:17:36

inovio-announces-publication-of-results-from-phase-1-proof-of-concept-trial-evaluating-dmabs-for-covid-19
INOVIO Announces Publication Of Results Fr...
10/21/2025 12:09:13

inovio-on-track-to-complete-ino-3107-biologics-license-application-by-2h25-targets-fda-acceptance-by-year-end
INOVIO On Track To Complete INO-3107 Biolo...
08/26/2025 12:09:51

Complete submission of the Biologics License Application (BLA) remains on track for 2H25 with the goal of file acceptance by U....

hc-wainwright--co-reiterates-neutral-on-inovio-pharmaceuticals-maintains-3-price-target
HC Wainwright & Co. Reiterates Neutral on ...
08/14/2025 11:29:58

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Inovio Pharmaceuticals (NASDAQ:INO) with a Neutral and maintai...

inovio-pharmaceuticals-q2-eps-061-beats-062-estimate
Inovio Pharmaceuticals Q2 EPS $(0.61) Beat...
08/12/2025 20:05:56

Inovio Pharmaceuticals (NASDAQ:INO) reported quarterly losses of $(0.61) per share which beat the analyst consensus estimate of...

Core News & Articles
Earnings Scheduled For August 12, 2025
08/12/2025 08:32:28

earnings-outlook-for-inovio-pharmaceuticals
Earnings Outlook For Inovio Pharmaceuticals
08/11/2025 18:02:16

inovios-announces-peer-reviewed-data-from-a-retrospective-study-investigating-the-long-term-clinical-and-safety-response-of-patients-treated-with-ino-3107-were-published-online-in-the-laryngoscope-ino-3107-shows-sustained-improvement-in-rrp-patients-cutting-surgeries-by-over-75-in-year-2
INOVIO's Announces Peer-reviewed Data From...
08/11/2025 12:09:36

Retrospective trial showed Overall Response Rate (ORR) improved to 86% at the end of the second 12-month period (Year 2) compar...

this-wingstop-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-wednesday
This Wingstop Analyst Begins Coverage On A...
07/09/2025 14:13:46

piper-sandler-initiates-coverage-on-inovio-pharmaceuticals-with-overweight-rating-announces-price-target-of-5
Piper Sandler Initiates Coverage On Inovio...
07/09/2025 12:24:59

Piper Sandler initiates coverage on Inovio Pharmaceuticals (NASDAQ:INO) with a Overweight rating and announces Price Target o...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/03/2025 21:05:44

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/03/2025 17:07:08

crude-oil-down-1-tripadvisor-shares-jump
Crude Oil Down 1%; Tripadvisor Shares Jump
07/03/2025 16:31:55

dow-jumps-over-200-points-us-nonfarm-payrolls-beat-estimates
Dow Jumps Over 200 Points; US Nonfarm Payr...
07/03/2025 14:08:15

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/03/2025 12:07:47

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION